Corrigendum to “The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement” [Leukemia Res. 100 (2021) 106480] (Leukemia Research (2021) 100, (S0145212620301855), (10.1016/j.leukres.2020.106480))

Colin P. Bergstrom, Saurabh Dahiya, Weina Chen, Cheng Cheng Zhang, Hong Zhu, Jingsheng Yan, Yazan Madanat, Prapti A Patel, Madhuri Vusirkala, Praveen Ramakrishnan, Syed Mujtaba Rizvi, Stephen Chung, Farrukh Awan, Larry D. Anderson, Robert Collins, Ankit Kansagra

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors would like to include the conflict of interest statement of Cheng Cheng Zhang, who had patent applications licensed to, holds equity in, has a sponsored research agreement with, and is a Scientific Advisory Board member with Immune-Onc Therapeutics. The authors would like to apologise for any inconvenience caused.

Original languageEnglish (US)
Article number106563
JournalLeukemia Research
Volume104
DOIs
StatePublished - May 2021

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Corrigendum to “The association of leukocyte immunoglobulin-like receptor subfamily B-4 expression in acute myeloid leukemia and central nervous system involvement” [Leukemia Res. 100 (2021) 106480] (Leukemia Research (2021) 100, (S0145212620301855), (10.1016/j.leukres.2020.106480))'. Together they form a unique fingerprint.

Cite this